Ad copy

Tori Spelling shares how she supports daughter Stella through mild to moderate eczema (atopic dermatitis), and finding treatments that fit her life. Approved Use ZORYVE (roflumilast) cream 0.15% is a prescription medicine used on the skin (topical) to treat mild to moderate eczema (atopic dermatitis) in adults and children 6 years of age and older. It is not known if ZORYVE cream 0.15% is safe and effective in children with mild to moderate eczema (atopic dermatitis) under 6 years of age. IMPORTANT SAFETY INFORMATION ZORYVE is for use on the skin (topical use) only. Do not use ZORYVE in or on your eyes, mouth, or vagina. Do not use ZORYVE if you have certain liver problems. Before using ZORYVE, tell your healthcare provider about all of your medical conditions, including if you: • have liver problems. • are pregnant or plan to become pregnant. It is not known if ZORYVE will harm your unborn baby. • are breastfeeding or plan to breastfeed. It is not known if ZORYVE passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with ZORYVE. Breastfeeding women using ZORYVE should use it on the smallest area of the skin and for the shortest time needed. Do not apply ZORYVE directly to the nipple or areola to avoid contact with your baby. Tell your healthcare provider about the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. The most common side effects of ZORYVE cream 0.15% include: • headache • nausea • application site pain • diarrhea • vomiting These are not all of the possible side effects of ZORYVE. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Please see Patient Information for ZORYVE through the link in the post copy, by visiting or clicking our bio @zoryve_roflumilast, or by visiting ZORYVE.com. For US audiences only. Talk to your doctor to see if ZORYVE cream 0.15% for mild to moderate eczema (age 6+) is right for you. Visit ZORYVE.com for more information. See @zoryve_roflumilast for Patient Information. #TeamZORYVE #ZORYVEPartner #SponsoredByArcutis #PaidSpokesperson © 2026 Arcutis Biotherapeutics, Inc. All rights reserved. US-COM-151-00598 05/26.